Stock Price Forecast

May 26, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Revvity Inc. chart...

About the Company

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.

CEO

Prahlad Singh

Exchange

NEW YORK STOCK EXCHANGE INC.

Website

www.perkinelmer.com

$5B

Total Revenue

17K

Employees

$15B

Market Capitalization

23.21

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $PKI News

Revvity's (RVTY) New Launch to Boost Tuberculosis Testing

8h ago, source:

Revvity's (RVTY) latest offering is likely to provide a new and improved workflow to lower hands-on time and enable increased lab productivity.

Revvity's EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings

11h ago, source:

Revvity's EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global ...

Revvity's (RVTY) Launch to Boost Pharma-Contract Partner Tie-Up

9d ago, source: Zacks.com on MSN

Revvity, Inc. RVTY recently announced that its software and informatics division, Revvity Signals, will launch Signals ...

Revvity Inc PKI

22d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Preliminary Injunction Granted to Enforce Revvity's Rights and Cloud Software Group's Obligations Related to Spotfire Software

23d ago, source: Stockhouse

Today, Revvity, Inc. (NYSE: RVTY) announced that the Massachusetts Superior Court has granted a preliminary injunction compelling Cloud Software Group (CSG) to comply with its contractual obligations ...

Revvity Signals to Host NEXUS India 2024 User Conference to Drive Knowledge Sharing and Innovation

7d ago, source: Asian News International on MSN

Revvity Signals Software, Inc., the software and informatics division of Revvity which is a leading provider of solutions for ...

Revvity Inc.

23d ago, source: Wall Street Journal

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Revvity's (RVTY) Launch to Boost Pharma-Contract Partner Tie-Up

9d ago, source: Nasdaq

Revvity, Inc. RVTY recently announced that its software and informatics division, Revvity Signals, will launch Signals Synergy. Per the company, it is a software solution designed to drive greater ...

Revvity, Inc

5d ago, source: moneycontrol.com

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Revvity Inc.

10d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...